NewsBenzingaNeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M Benzinga 2026.10.05 13:21 (GMT+0) Open on Benzinga Other news Barclays Maintains Underweight on First Interstate BancSys, Raises Price Target to $38 Here's How Much $1000 Invested In First BanCorp 10 Years Ago Would Be Worth Today Barclays Maintains Overweight on First American Financial, Lowers Price Target to $79 Barclays Maintains Equal-Weight on Fidelity National Finl, Lowers Price Target to $47 Barclays Maintains Equal-Weight on Essent Group, Raises Price Target to $66 Barclays Maintains Equal-Weight on Eastern Bankshares, Raises Price Target to $23
